Reaction
Arrhythmia Supraventricular reporting signals
As of the last recalculation, Arrhythmia Supraventricular appears in 1,087 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is DOFETILIDE (PRR 18.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dofetilide | 10 | 18.4 | 18.4 |
| Apalutamide | 9 | 14.8 | 14.8 |
| Amlodipine Besylate And Benazepril Hydrochloride | 7 | 14.6 | 14.6 |
| Digoxin | 51 | 14.2 | 14.2 |
| Leucovorin Calcium | 14 | 14.2 | 14.2 |
| Amiodarone Hydrochloride | 8 | 13.8 | 13.8 |
| Insulin Glulisine | 7 | 13.3 | 13.3 |
| Thalidomide | 24 | 12.8 | 12.8 |
| Cetirizine Hcl | 6 | 12.6 | 12.6 |
| Bupivacaine | 6 | 12.4 | 12.4 |
| Nebivolol | 10 | 12.1 | 12.1 |
| Terbinafine Hydrochloride | 5 | 10.8 | 10.8 |
| Sevoflurane | 4 | 9.2 | 9.2 |
| Norepinephrine | 5 | 9.0 | 9.0 |
| Bevacizumab | 55 | 8.9 | 8.9 |
| Bendamustine Hcl | 7 | 8.7 | 8.7 |
| Panitumumab | 7 | 8.6 | 8.6 |
| Memantine | 6 | 8.4 | 8.4 |
| Memantine Hydrochloride | 6 | 8.4 | 8.4 |
| Temozolomide | 9 | 8.2 | 8.2 |
| Ibrutinib | 31 | 7.5 | 7.5 |
| Tafamidis | 4 | 6.5 | 6.5 |
| Cetuximab | 9 | 5.5 | 5.5 |